Understanding Muscle Dysfunction in Chronic Fatigue Syndrome.
Rutherford, Gina, Manning, Philip, Newton, Julia L · Journal of aging research · 2016 · DOI
Quick Summary
This review examined research showing that people with ME/CFS may have problems with how their muscles produce and use energy. Specifically, their muscles appear to rely too heavily on a less efficient energy pathway (lactate dehydrogenase) during and after exercise, and they have difficulty clearing the acidic byproducts that build up. These muscle-level energy problems could explain why ME/CFS patients experience severe fatigue and difficulty maintaining physical activity.
Why It Matters
Understanding that ME/CFS involves measurable muscle-level energy metabolism problems provides biological validation for patients' experiences and shifts focus from psychological explanations to treatable biochemical dysfunction. This work supports the need for interventions targeting bioenergetic pathways and exercise protocols that account for abnormal lactate metabolism and acid clearance.
Observed Findings
Skeletal muscle bioenergetic dysfunction is evident in ME/CFS patients
Patients show abnormal overutilization of the lactate dehydrogenase pathway following low-level exercise
Acid clearance is slowed after physical activity in ME/CFS
These muscle biochemical abnormalities correlate with patient-reported difficulty maintaining muscle activity and perceived lack of energy
Immune, oxidative, mitochondrial, and neuronal pathway dysfunction may contribute to muscle pathology
Inferred Conclusions
Bioenergetic muscle dysfunction represents a core pathophysiological mechanism in ME/CFS rather than a psychological phenomenon
Abnormal lactate metabolism and impaired acid clearance may directly explain the severe fatigue and post-exertional malaise experienced by patients
CFS/ME should be understood as a disorder with demonstrable biochemical pathology at the muscle level
Remaining Questions
What is the relative contribution of lactate pathway dysfunction versus mitochondrial impairment in driving bioenergetic abnormalities?
Do these muscle biochemical abnormalities vary by CFS/ME subtype or disease severity, and are they present in all patients or only subsets?
What This Study Does Not Prove
This review does not establish causation—abnormal lactate metabolism and acid clearance could be consequences rather than causes of ME/CFS. It does not identify which molecular mechanisms are primary drivers versus secondary effects, nor does it prove these findings apply uniformly across all ME/CFS patients. As a narrative review synthesis, it cannot validate the methodological quality of included studies or establish definitive prevalence of these findings.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.